Aura Biosciences AURA
NASDAQ AURA
$6.09 +0.05 (+0.83%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aura Biosciences (AURA) Non Operating Investment Income (2021 - 2022)

Updated

Aura Biosciences (AURA) posted Non Operating Investment Income of $208,000 for FY2023, compared with -$318,000 in FY2022.

Analysis

Aura Biosciences (AURA) Non Operating Investment Income (2021 - 2022) Analysis & Trends

  • Business Quant data shows AURA's Non Operating Investment Income at -$318,000 in FY2022 and -$3,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Aura Biosciences 630.19 Mn 370.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -313,000.00
Mar 31, 2022 -5,000.00
Mar 31, 2021 -3,000.00
API Access

Aura Biosciences Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=AURA&period=max&api_key=YOUR_API_KEY